Aroa Biosurgery Ltd has released a press release.
March 2025 Quarterly Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Aroa Biosurgery
- December 2024 Quarterly Report and Appendix 4C
- Aroa Half Year Results Presentation
- Aroa Biosurgery Half Yearly Results H1 FY25
- September 2024 Quarterly Report and Appendix 4C
- June 2024 Quarterly Report and Appendix 4C
Later from Aroa Biosurgery
- AROA hits evidence milestone with real-world study validating the efficacy of Endoform in treating challenging venous leg ulcers.
- FY25 Appendix 4E and Full Year Results
- FY25 Full Year Results Presentation
- June 2025 Quarterly Report and Appendix 4C
- First clinical evidence published on AROA's ENIVO™ system for surgical dead space management.
Follow Aroa Biosurgery into a list and get an email when it puts out news.
Follow Aroa Biosurgery